While ideological opponents continue to do everything they can to eliminate Medicare Advantage, the research evidence continues to show benefits from the program over traditional fee-for-service Medicare. (NBER Paper) To avoid selection bias issues which might result from unobservably healthier beneficiaries enrolling in Medicare Advantage, the authors used a feature of Medicare Advantage payments that gives higher reimbursement to plans in counties with populations over 250,000 as a basis for analysis. While it is generally unquestioned that Medicare pays Medicare Advantage more for a particular beneficiary than that beneficiary would cost in traditional Medicare, that is an intentional political decision that Congress made. Whether or not more is actually spent on their care is a different question, as is the issue of comparative quality. At this point, there appears to be accumulating evidence that quality is better in Medicare Advantage plans. And there is more evidence than not that there is lower utilization, particularly of low-value services, in the Medicare Advantage plans. The authors try to extend these analyses by finding a way to eliminate unknown variables between the Medicare Advantage and fee-for-service populations. They compared outcomes from beneficiaries in counties with populations from 100,000 to 249,999 to counties with populations from 250,000 to 400,000 persons. They incorporate beneficiary and country characteristics into their analysis. The larger, higher Medicare Advantage reimbursement counties have more Medicare Advantage enrollment, as might be expected. After all the adjustments, the analysis shows over a 20% reduction in hospital admissions for Medicare Advantage, along with lower mortality, demonstrating once again that Medicare Advantage plans are likely delivering more appropriate care, usually with better outcomes.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
In truth, this seems like more money down a rathole. Google’s parent and other investors are putting a billion dollars into Google’s health arm, Verily. Apparently want to compete with...
September 12, 2022
It is like investors have learned nothing from the past two years. Even supposedly smart investors like Morgan Health, which is making a $20 million contribution to LetsGetChecked, which supposedly...
September 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace